| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | -0.033 | 0.4 |
| mRNA | ML334 diastereomer | CTRPv2 | pan-cancer | AAC | -0.036 | 0.4 |
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | -0.027 | 0.4 |
| mRNA | SNX-2112:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.026 | 0.4 |
| mRNA | BRD-K78574327 | CTRPv2 | pan-cancer | AAC | 0.056 | 0.4 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.025 | 0.4 |
| mRNA | NVP-231 | CTRPv2 | pan-cancer | AAC | 0.025 | 0.4 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | -0.041 | 0.4 |
| mRNA | WZ4002 | CTRPv2 | pan-cancer | AAC | 0.034 | 0.4 |
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | 0.26 | 0.4 |